Planned sales, announced before they happen
1 trading plan running, 14 Form 144 notices for $66.7M
Plans running now
1
Dean A. Manson
What ECHO's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Trading plans
Plans adopted or ended
| Insider | What | Date | Shares | Runs to | Reported in |
|---|---|---|---|---|---|
| Hamid Akhavan Chief Executive Officer |
Adopted 10b5-1 plan | Mar 6, 2026 | up to 142,917 | Jun 12, 2026 | 10-Q May 11, 2026 |
What the company wroteOn March 6, 2026, Hamid Akhavan, Chief Executive Officer, EchoStar Capital, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) for the potential sale of up to 142,917 shares (including certain options that expire on April 1, 2034) of our Class A common stock, subject to certain conditions. The arrangement's expiration date is June 12, 2026. | |||||
| Dean A. Manson Chief Legal Officer and Secretary |
Adopted 10b5-1 plan | Mar 5, 2026 | up to 53,700 | Mar 5, 2027 | 10-Q May 11, 2026 |
What the company wroteOn March 5, 2026, Dean A. Manson, Chief Legal Officer and Secretary adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) for the potential sale of up to 53,700 shares (including certain options that expire on April 1, 2034) of our Class A common stock, subject to certain conditions. The arrangement's expiration date is March 5, 2027. | |||||
| Paul W. Orban Executive Vice President and Chief Financial Officer |
Ended 10b5-1 plan | Dec 9, 2025 | up to 52,874 | – | 10-K Mar 2, 2026 |
What the company wroteOn December 9, 2025, Paul W. Orban, Executive Vice President and Chief Financial Officer, terminated his Rule 10b5-1 Plan dated September 12, 2025 for the potential sale of up to 52,874 shares of our Class A common stock. | |||||
| Hamid Akhvan President and Chief Executive Officer and a member of our Board of Directors |
Adopted 10b5-1 plan | Sep 12, 2025 | up to 285,832 | Sep 11, 2026 | 10-Q Nov 6, 2025 |
What the company wroteOn September 12, 2025, Hamid Akhvan, President and Chief Executive Officer and a member of our Board of Directors, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) for the potential sale of up to 285,832 shares (including certain options that expire on April 1, 2034) of our Class A common stock, subject to certain conditions. The arrangement's expiration date is September 11, 2026. | |||||
| Paul Orban Executive Vice President and Chief Financial Officer |
Adopted 10b5-1 plan | Sep 12, 2025 | up to 52,874 | Sep 11, 2026 | 10-Q Nov 6, 2025 |
What the company wroteOn September 12, 2025, Paul Orban, Executive Vice President and Chief Financial Officer, DISH, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) for the potential sale of up to 52,874 shares (including certain options that expire on April 1, 2034) of our Class A common stock, subject to certain conditions. The arrangement's expiration date is September 11, 2026. | |||||
| Paul Orban Executive Vice President and Chief Financial Officer |
Adopted 10b5-1 plan | Dec 3, 2024 | up to 81,211 | Dec 2, 2025 | 10-K Feb 27, 2025 |
What the company wroteOn December 3, 2024 , Paul Orban , Executive Vice President and Chief Financial Officer , DISH, adopted a Rule 10b5-1 trading arrangement for the potential sale of up to 81,211 shares (including certain options that expire on April 1, 2034) of our common stock, subject to certain conditions. The arrangement's expiration date is December 2, 2025 . | |||||
| Dean Manson Chief Legal Officer and Secretary |
Adopted 10b5-1 plan | Nov 26, 2024 | up to 30,000 | Nov 25, 2025 | 10-K Feb 27, 2025 |
What the company wroteOn November 26, 2024 , Dean Manson , Chief Legal Officer and Secretary , adopted a Rule 10b5-1 trading arrangement for the potential sale of up to 30,000 shares (including certain options that expire on April 1, 2034) of our common stock, subject to certain conditions. The arrangement's expiration date is November 25, 2025 . | |||||
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 16 filings checked since May 9, 2023.
Form 144
Notices of planned sales
| Filed | Seller | Shares | Value | Shares came from | 10b5-1 plan | Form 4 sales after |
|---|---|---|---|---|---|---|
| Aug 25, 2026 | Wade William David Director |
5,000 | $459K | Option Exercise | none given | none found |
| Aug 7, 2026 | BYE STEPHEN J Director |
8,508 | $764K | Stock Option Exercise | none given | 8,508 shares from Aug 7, 2026 |
| Aug 6, 2026 | Akhavan Hamid Former Officer and Director |
26,567 | $2.3M | Stock Option Exercise | none given | none found |
| Aug 5, 2026 | Akhavan Hamid Former Officer and Director |
26,563 | $2.4M | Stock Option Exercise | none given | none found |
| Aug 4, 2026 | Akhavan Hamid Former Officer & Director |
52,000 | $4.7M | Stock Option Exercise | none given | none found |
| Jun 12, 2026 | Manson Dean Officer |
10,000 | $1.3M | Stock Option Exercise | adopted Mar 5, 2026 | 10,000 shares from Jun 12, 2026 |
| Jun 5, 2026 | Akhavan Hamid Officer, Director |
52,586 | $6.4M | Stock Option Exercise | adopted Mar 6, 2026 | 52,586 shares from Jun 5, 2026 |
| Jun 4, 2026 | Manson Dean Officer |
10,000 | $1.2M | Stock Option Exercise | adopted Mar 5, 2026 | 20,000 shares from Jun 4, 2026 |
| Mar 6, 2026 | Akhavan Hamid Officer, Director |
71,005 | $7.6M | Option Granted - 12/31/2023 | none given | none found |
| Mar 5, 2026 | Manson Dean Officer |
19,031 | $2.2M | Option Granted - 04/01/2024 | none given | none found |
| Mar 4, 2026 | Swieringa John Officer |
50,088 | $5.7M | ESPP Purchase; Option Granted - 01/01/2024; Restricted Stock Vesting | none given | none found |
| Dec 11, 2025 | Akhavan Hamid Officer, Director |
285,832 | $30.1M | Option Granted 04/01/2024 | adopted Sep 12, 2025 | none found |
| Dec 11, 2025 | Ortolf Tom A Director |
1,754 | $183K | Options Granted - 01/01/2021 | none given | none found |
| Nov 21, 2025 | Swieringa John Officer |
22,000 | $1.5M | Restricted Stock Vesting | none given | none found |
Show the other 6 notices
From the Form 144 XML filed with the SEC, since Nov 21, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.